Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: ST-segment elevation myocardial infarction (STEMI) with high thrombus burden is associated with a poor prognosis. Manual aspiration thrombectomy reduces coronary vessel distal embolisation, improves microvascular perfusion and reduces cardiovascular deaths, but it promotes more strokes and transient ischaemic attacks in the subgroup with high thrombus burden. Intrathrombus thrombolysis (ie, the local delivery of thrombolytics into the coronary thrombus) is a recently proposed treatment approach that theoretically reduces thrombus volume and the risk of microvascular dysfunction. However, the safety and efficacy of intrathrombus thrombolysis lack sufficient clinical evidence.
Methods And Analysis: The intrAThrombus Thrombolysis versus aspiRAtion thrombeCTomy during prImary percutaneous coronary interVEntion trial is a multicentre, prospective, open-label, randomised controlled trial with the blinded assessment of outcomes. A total of 2500 STEMI patients with high thrombus burden who undergo primary percutaneous coronary intervention will be randomised 1:1 to intrathrombus thrombolysis with a pierced balloon or upfront routine manual aspiration thrombectomy. The primary outcome will be the composite of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, heart failure readmission, stent thrombosis and target-vessel revascularisation up to 180 days.
Ethics And Dissemination: The trial was approved by Ethics Committees of China-Japan Friendship Hospital (2022-KY-013) and all other participating study centres. The results of this trial will be published in peer-reviewed journals.
Trial Registration Number: NCT05554588.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649700 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2023-076476 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Periodontitis in ischemic stroke: impact of on thrombus composition and ischemic stroke outcomes.
Res Pract Thromb Haemost
January 2024
Institut National de la Santé et de la Recherche Médicale, Laboratory for Vascular Translational Research, Université Paris Cité and Université Sorbonne Paris Nord, Paris, France.
Article Synopsis
- Periodontitis is linked to a higher risk of ischemic stroke, but the reasons behind this connection are not well understood.
- Researchers aimed to find out if a specific periodontal bacterium, Pg, can be found in blood clots from stroke patients and how it affects treatment outcomes.
- Results showed Pg was present in about 33.7% of blood clots, with those containing Pg experiencing lower rates of successful reperfusion and less favorable neurological outcomes after 3 months, indicating that Pg may contribute to increased inflammation and resistance to therapy.
NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6C Monocytes/Macrophages Differentiation to Accelerate Thrombolysis.
Adv Sci (Weinh)
April 2024
Department of Pathology and Pathophysiology, and Department of Respiratory Medicine at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Article Synopsis
- Tumor-associated thrombus (TAT) significantly contributes to venous thromboembolism, complicating treatment and sometimes resulting in death before the tumor itself can be addressed.
- The study highlights the role of myeloid SHP2 deficiency in enhancing monocyte/macrophage differentiation and promoting thrombus resolution by boosting the activity of enzymes like MMP2/9.
- A novel delivery system called NanoSHP099 was developed, showing improved targeting and thrombolytic effects in cancer research, performing better than regular SHP099 in reducing both tumor size and thrombus burden.
Design and rationale of the ATTRACTIVE trial: a randomised trial of intrAThrombus Thrombolysis versus aspiRAtion thrombeCTomy during prImary percutaneous coronary interVEntion in ST-segment elevation myocardial infarction patients with high thrombus burden.
BMJ Open
November 2023
Department of Cardiology, China-Japan Friendship Hospital, Beijing, China
Introduction: ST-segment elevation myocardial infarction (STEMI) with high thrombus burden is associated with a poor prognosis. Manual aspiration thrombectomy reduces coronary vessel distal embolisation, improves microvascular perfusion and reduces cardiovascular deaths, but it promotes more strokes and transient ischaemic attacks in the subgroup with high thrombus burden. Intrathrombus thrombolysis (ie, the local delivery of thrombolytics into the coronary thrombus) is a recently proposed treatment approach that theoretically reduces thrombus volume and the risk of microvascular dysfunction.
View Article and Find Full Text PDFMicrostructure aware modeling of biochemical transport in arterial blood clots.
J Biomech
October 2021
Paul M Rady Department of Mechanical Engineering, University of Colorado Boulder, United States of America. Electronic address:
Flow-mediated transport of biochemical species is central to thrombotic phenomena. Comprehensive three-dimensional modeling of flow-mediated transport around realistic macroscale thrombi poses challenges owing to their arbitrary heterogeneous microstructure. Here, we develop a microstructure aware model for species transport within and around a macroscale thrombus by devising a custom preconditioned fictitious domain formulation for thrombus-hemodynamics interactions, and coupling it with a fictitious domain advection-diffusion formulation for transport.
View Article and Find Full Text PDFComparative outcomes of catheter-directed thrombolysis plus rivaroxaban vs rivaroxaban alone in patients with acute iliofemoral deep vein thrombosis.
J Chin Med Assoc
December 2019
Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Background: Since novel oral anticoagulants (NOACs) have been introduced in the past decade, the first option of deep vein thrombosis (DVT) treatment is toward NOACs. However, aggressive and early thrombus removal strategy is widely used for treating acute iliofemoral DVT. Consequently, optimal treatment duration, efficacy, and safety of rivaroxaban alone or in combination with catheter-directed intrathrombus thrombolysis (CDT) in acute iliofemoral DVT patients should be investigated.
View Article and Find Full Text PDF